Free Trial

Kestra Private Wealth Services LLC Has $928,000 Holdings in Celestica, Inc. (NYSE:CLS)

Celestica logo with Computer and Technology background

Kestra Private Wealth Services LLC lessened its stake in shares of Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS by 11.4% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 11,780 shares of the technology company's stock after selling 1,510 shares during the quarter. Kestra Private Wealth Services LLC's holdings in Celestica were worth $928,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. FMR LLC grew its stake in shares of Celestica by 91.2% in the fourth quarter. FMR LLC now owns 11,688,700 shares of the technology company's stock worth $1,078,804,000 after purchasing an additional 5,574,342 shares during the last quarter. FIL Ltd grew its stake in shares of Celestica by 5,976.1% in the fourth quarter. FIL Ltd now owns 3,463,729 shares of the technology company's stock worth $319,662,000 after purchasing an additional 3,406,723 shares during the last quarter. Norges Bank bought a new stake in shares of Celestica in the fourth quarter worth $139,008,000. Polar Capital Holdings Plc grew its stake in shares of Celestica by 822.6% in the fourth quarter. Polar Capital Holdings Plc now owns 1,607,969 shares of the technology company's stock worth $148,416,000 after purchasing an additional 1,433,681 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its stake in shares of Celestica by 64.6% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 3,572,988 shares of the technology company's stock worth $329,460,000 after purchasing an additional 1,401,877 shares during the last quarter. Institutional investors own 67.38% of the company's stock.

Celestica Stock Up 3.7%

Shares of CLS stock traded up $6.01 on Friday, reaching $169.99. 2,581,941 shares of the company were exchanged, compared to its average volume of 3,187,565. The company has a market cap of $19.55 billion, a price-to-earnings ratio of 46.83 and a beta of 1.81. The company has a 50-day moving average of $139.83 and a 200-day moving average of $113.46. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.43 and a quick ratio of 0.85. Celestica, Inc. has a one year low of $40.25 and a one year high of $173.63.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last released its quarterly earnings data on Thursday, April 24th. The technology company reported $1.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.10 by $0.10. The company had revenue of $2.65 billion for the quarter, compared to analysts' expectations of $2.56 billion. Celestica had a net margin of 4.26% and a return on equity of 25.57%. The business's revenue was up 19.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.83 EPS. Analysts anticipate that Celestica, Inc. will post 4.35 earnings per share for the current year.

Analyst Ratings Changes

Several analysts recently weighed in on CLS shares. Citigroup started coverage on shares of Celestica in a research note on Monday, July 21st. They issued a "neutral" rating and a $172.00 price objective on the stock. CIBC cut their price target on shares of Celestica from $150.00 to $120.00 and set an "outperformer" rating on the stock in a research report on Tuesday, April 15th. Argus cut their price target on shares of Celestica from $150.00 to $120.00 and set a "buy" rating on the stock in a research report on Tuesday, April 29th. Barclays reaffirmed an "overweight" rating and set a $146.00 price target (up previously from $126.00) on shares of Celestica in a research report on Tuesday, June 10th. Finally, JPMorgan Chase & Co. upped their price target on shares of Celestica from $115.00 to $170.00 and gave the company an "overweight" rating in a research report on Thursday, July 17th. Three investment analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Celestica presently has an average rating of "Moderate Buy" and an average price target of $125.83.

Check Out Our Latest Report on CLS

Celestica Company Profile

(Free Report)

Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.

Further Reading

Institutional Ownership by Quarter for Celestica (NYSE:CLS)

Should You Invest $1,000 in Celestica Right Now?

Before you consider Celestica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.

While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines